How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study

Addiction

Volumn 105, Issue 6, 2010, Pages 951-953

  Griffiths, Paul ^a   Sedefov, Roumen ^a   Gallegos, Ana ^a   Lopez, Dominique ^a  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

Author keywords

'Spice'; Drug control; Internet; Synthetic cannabinoids

Indexed keywords

CANNABINOID; PLANT MEDICINAL PRODUCT;

CHEMISTRY; EDITORIAL; HUMAN; INTERNATIONAL COOPERATION; INTERNET; MARKETING; MEDICINAL PLANT;

CANNABINOIDS; HUMANS; INTERNATIONALITY; INTERNET; MARKETING; PLANT PREPARATIONS; PLANTS, MEDICINAL;

EID: 77951989152     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02874.x     Document Type: Review

References (12)

1. Early Warning System. Available at: http://www.emcdda.europa.eu/themes/ new-drugs/early-warning (accessed 23 October 2009).
2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Thematic Papers - Understanding the 'Spice' Phenomenon. Lisbon: EMCDDA 2009. Available at: http://www.emcdda.europa.eu/html.cfm/index90917EN.html (accessed 23 October 2009).
3. Auwärter V., Dresen S., Weinmann W., Müller M., Pütz M., Ferreirós N. Spice and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 2009 44 : 832 837.
4. Compton D. R., Johnson M. R., Melvin L. S., Martin B. R. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J Pharmacol Exp Ther 1992 260 : 201 209.
5. Compton D. R., Rice K. C., de Costa B. R., Razdan R. K., Melvin L. S., Johnson M. R. et al. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 1993 265 : 218 226.
6. Huffman J. W. Cannabimimetic indoles, pyrroles, and indenes: structure-activity relationships and receptor interactions. In : Reggio P. H., editor. The Cannabinoid Receptors.
7. Lindigkeit R., Boehme A., Eiserloh I., Luebbecke M., Wiggermann M., Ernst L. et al. Spice: a never ending story? Forensic Sci Int 2009 191 : 58 63.
8. United States Drug Enforcement Administration, Office of Forensic Sciences. 'Spice' - plant material(s) laced with synthetic cannabinoids or cannabinoid mimicking compounds. Microgram Bulletin, March 2009. Available at: http://www.justice.gov/dea/programs/forensicsci/microgram/mg0309/mg0309.html (accessed 7 January 2010).
9. Uchiyama N., Kikura-Hanajiri R., Kawahara N., Haishima Y., Goda Y. Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem Pharm Bull 2009 57 : 439 441.
10. Zimmermann U. S., Winkelmann P. R., Pilhatsch M., Nees J. A., Spanagel R., Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of 'spice gold'. Dtsch Arztebl Int 2009 106 : 464 467.
11. McLachlan G. Taking the spice out of legal smoking mixtures. Lancet 2009 374 : 600.
12. Advisory Council on the Misuse of Drugs. Consideration of the Major Cannabinoid Agonists. 2009. Available at: http://drugs.homeoffice.gov.uk/drugs- laws/acmd/ (accessed 23 October 2009).